Songklanagarind Hospital is a university teaching hospital, affiliated to the Faculty of Medicine of Prince of Songkla University, located in Hat Yai District, Songkhla Province. It is a hospital capable of super tertiary care and is the first university hospital in Southern Thailand.

There are 1,000 beds in Songklanagarind Hospital.

During the past decade, Songklanagarind Hospital conducted 47 clinical trials. In the 10-year time frame, 47 clinical trials started and 20 clinical trials were completed, i.e. on average, 42.6% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 9 clinical trials were completed. i.e. 40.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Songklanagarind Hospital" #1 sponsor was "Prince of Songkla University" with 16 trials, followed by "Boehringer Ingelheim" with 9 trials sponsored, "Janssen Research & Development, LLC" with 5 trials sponsored, "Pfizer" with 5 trials sponsored and "Astellas Pharma Inc" with 5 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Songklanagarind Hospital" #1 collaborator was "Basilea Pharmaceutica International Ltd" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Allergan" with 1 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator and "Amgen" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Songklanagarind Hospital" are "Carcinoma, Non-Small-Cell Lung" (7 trials), "Non Small Cell Lung Cancer" (3 trials), "Adenocarcinoma" (2 trials), "Adult Disease" (2 trials) and "Advanced Solid Tumors" (2 trials). Many other conditions were trialed in "Songklanagarind Hospital" in a lesser frequency.

Most popular intervention types in "Songklanagarind Hospital" are "Drug" (57 trials), "Device" (10 trials), "Biological" (3 trials), "Other" (3 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Carboplatin" (5 trials), "Paclitaxel" (4 trials), "Pemetrexed" (4 trials) and "ATM-AVI" (2 trials). Other intervention names were less common.

The vast majority of trials in "Songklanagarind Hospital" are 68 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Songklanagarind Hospital". undefined are not yet recruiting, 10 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 39 completed trials in Songklanagarind Hospital, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Songklanagarind Hospital, 4 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 10 trials that are defined as “Not Applicable".

Songklanagarind Hospital has several departments that took part in Clinical trials: "Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine, Prince of Songkla University" - 24 trials, "Songklanagarind Hospital; Department of Oncology" - 16 trials, "Songklanagarind Hospital; Department of Internal Medicine, Division of Respiratory" - 7 trials, "Songklanagarind Hospital; Department of Surgery" - 5 trials, "Department of Ophthalmology, Faculty of Medicine, Prince of Songkla University" - 4 trials, "NKC Institute of Gastroenterology and Hepatology/Songklanagarind Hospital" - 2 trials, "Department of anesthesiology, Faculty of Medicine, Prince of Songkla University" - 2 trials, "Sasikaan Nimmaanrat" - 2 trials, "Prince of Songkla University; Division of Pulmonary Disease, Department of Medicine" - 2 trials, "Heart Center, Songklanagarind Prince of Songkla University" - 2 trials